health
By Emma Farge, Jennifer Rigby, Olivia Le Poidevin and Aaron Ross
NAIROBI/LONDON/GENEVA, June 9 (Reuters) – Nearly a month into one of the world’s largest ever Ebola outbreaks, medics in eastern Democratic Republic of Congo are struggling to secure basic equipment to stay safe and prevent further spread of the...
Read More
The Media Line: Lifestyle Changes May Protect Against Diabetes Even After Weight Regain: Ben-Gurion Study
Lifestyle Changes May Protect Against Diabetes Even After Weight Regain: Ben-Gurion Study
By The Media Line Staff
Researchers at Ben-Gurion University of the Negev and partner institutions said Wednesday that lifestyle-driven reductions in deep abdominal fat may protect...
Read More
The Media Line: Large-Scale Israeli Study Finds No Increased Birth Defect Risk From Common Pregnancy Painkillers
Large-Scale Israeli Study Finds No Increased Birth Defect Risk From Common Pregnancy Painkillers
By The Media Line Staff
Researchers at Ben-Gurion University of the Negev have published two large-scale studies involving more than 264,000 pregnancies that found no...
Read More
health Headlines
Judge considers arguments in challenge to New Mexico’s universal childcare program- Humana divests minority stake in hospice provider Gentiva
- OB-GYN group makes vaccine recommendations for the first time
- Health sleuths are watching for disease threats during the World Cup
- Motorcycle taxi drivers in Congo rally for Ebola awareness as attacks hinder response
- Congo’s Ebola outbreak spreads to new health zone
- US doctor isolated in Czech hospital for Ebola monitoring released, heading home
- Italy fines Philip Morris €7 million over ‘smoke-free’ marketing claims
- Ebola testing stalled in three Congo labs due to shortages, says WHO
- Two babies from Congo orphanage die of Ebola, highlighting risk to children
- Apotex Health shares jump in largest Toronto stock market IPO since 2021
- Organon wins US approval to widen use of arthritis biosimilar drug
- Pfizer CEO warns German investment at risk over drug pricing policies
- Older drug reprograms white blood cells, improves blood sugar in type 1 diabetes
- Novo Nordisk faces off in court with South African weight-loss drug compounder
- Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
- Sanofi ends Phase 3 riliprubart trial after weak interim results
- Law firms cheated in filing claims with NFL’s $1 billion concussion settlement fund, report says
- US urges Europe to step up travel measures to prevent spread of Ebola from Africa
- Canadian health firm Apotex prices IPO at top end, raising C$1.3 billion
- Australia’s Sigma in early talks to acquire British pharmacy Boots
- Mexico blocks most imports of live animals from US after screwworm cases
- Congo says number of confirmed Ebola cases rises to nearly 600
- US urges Europe to impose Ebola travel bans ahead of World Cup
- The Media Line: What Could Happen When Israel’s Pharma Giant Meets Its Most Innovative Hospital?
- Social Security’s retirement trust fund faces a funding shortfall a year earlier than expected
- FDA OKs first new sunscreen ingredient in more than 25 years
- US NIH names John Powers III as acting director of infectious disease institute
- UK’s Boots in talks for $10 billion sale as owners plan to scrap IPO plans, FT reports
- Samsung Elec invests $175 million to become top shareholder in US genetics firm
- Trump administration warns over 500 hospitals to provide more price information or face fines
- FDA expands sunscreen options with first new ingredient since 1990s
- India’s Ajanta Pharma promoter sells stake worth about 10.24 billion rupees
- Playing hip-hop or Doris Day, older exercise instructors can speak their peers’ language
- Three more US passengers from hantavirus-hit ship return to home states
- Sidelined US research on alcohol’s health effects published in independent journal
- A government-commissioned study found drinking risks. US guidelines didn’t feature its findings
- Europe faces growing synthetic opioids risks as drug market evolves, EU agency warns
- Cholera outbreak in Nigeria’s Borno kills 74, infects thousands since May
- Congo Ebola contact tracing is below target but has improved, WHO says
- Parabilis Medicines targets $2.3 billion valuation in upsized US IPO
- Cancer vaccines based on mRNA advance, despite US cuts
- Indian cancer patients battle shortage of key drugs as platinum costs surge
- UK reviewing Palantir’s NHS contract amid pressure to use break clause
- Roche sticks to German investment after Eli Lilly cuts
- Kenyan protester killed at demonstration against US Ebola facility, witnesses say
- AlzeCure signs collaboration, out-licensing deal with Lilly for Alzheimer’s drug
- GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover
- GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports
- Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests
